FDA Inspection 857298 — Omthera Pharmaceuticals

Omthera Pharmaceuticals — FEI 3010408506

The FDA completed an inspection of Omthera Pharmaceuticals on Nov 5, 2013 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 5, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
740921 CFR 312.53(b)Shipment to unauthorized persons
745921 CFR 312.57(a)Records of receipt, shipment, disposition
748221 CFR 312.50General responsibilities of sponsors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.